Müllerian agenesis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Müllerian agenesis | |
|---|---|
| Synonyms | Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Absence of vagina, uterus, and/or cervix |
| Complications | Infertility, sexual dysfunction |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Unknown, possibly genetic |
| Risks | Family history |
| Diagnosis | Pelvic ultrasound, MRI, laparoscopy |
| Differential diagnosis | Androgen insensitivity syndrome, transverse vaginal septum |
| Prevention | N/A |
| Treatment | Vaginal dilation, surgical creation of a neovagina |
| Medication | N/A |
| Prognosis | Good with treatment |
| Frequency | 1 in 4,500 to 5,000 female births |
| Deaths | N/A |

Müllerian agenesis, also known as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, is a congenital condition characterized by the underdevelopment or absence of the uterus and the upper part of the vagina in females, while the external genitalia and the development of secondary sexual characteristics (such as breasts) remain normal. This condition is named after the physicians who first described it: August Franz Joseph Karl Mayer, Carl Freiherr von Rokitansky, Hermann Küster, and G.A. Hauser.
Etiology and Pathogenesis[edit]
The exact cause of Müllerian agenesis is unknown, but it is believed to involve a combination of genetic, environmental, and possibly hormonal factors. The condition results from the failure of the Müllerian ducts to develop properly during fetal development. These ducts are precursors to the female reproductive tract, including the fallopian tubes, uterus, cervix, and the upper part of the vagina.
Clinical Presentation[edit]
Individuals with Müllerian agenesis typically present with primary amenorrhea, which is the absence of menstruation by the age of 16, despite normal development of secondary sexual characteristics. They may also experience cyclic pelvic pain due to the accumulation of menstrual blood in the vaginal or uterine remnants. Since the ovaries are usually normal, individuals with this condition may experience normal puberty and have a normal female karyotype (46,XX).
Diagnosis[edit]
Diagnosis of Müllerian agenesis is often made based on the clinical presentation, including the history of primary amenorrhea and normal secondary sexual characteristic development. Pelvic ultrasound or magnetic resonance imaging (MRI) can confirm the absence or underdevelopment of the uterus and vagina. Karyotyping may be performed to exclude chromosomal abnormalities.
Management[edit]
The management of Müllerian agenesis focuses on the psychological and reproductive aspects of the condition. Psychological counseling is important to address any emotional or psychological issues. For those desiring to have a functional vagina, vaginal reconstruction can be performed using various surgical techniques or through non-surgical methods such as the use of vaginal dilators. Assisted reproductive technologies, such as in vitro fertilization (IVF) with a gestational carrier, may be options for individuals wishing to have biological children.
Prognosis[edit]
The long-term prognosis for individuals with Müllerian agenesis is generally good, especially with appropriate management of the condition. Psychological support and counseling play a crucial role in helping individuals cope with the diagnosis and its implications.
Epidemiology[edit]
Müllerian agenesis is a rare condition, affecting approximately 1 in 4,500 female births. However, the exact prevalence may vary due to underreporting and differences in diagnostic criteria.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
